A randomized clinical trial with natural interferon-α monotherapy for 24 or 48 weeks on patients with chronic hepatitis C having genotype 1b infection in high viral titers

Hepatology Research

Volumn 24, Issue 4, 2002, Pages 338-345

  Iino, Shiro ^a   Ichida, Fumihiro ^b   Sakuma, Akira ^c   Suzuki, Hiroshi ^d   Matsushima, Takashi ^e   Chiba, Mitsurou ^f   Yoshida, Tsukasa ^g   Yasuda, Kiyomi ^h   Suzuki, Michichiro ^a   Ichida, Takafumi ⁱ   Kamimura, Tomoteru ^j   Akahane, Yoshihiro ^d   Ikeda, Masanobu ^k   Takeda, Kiyoshi ^l   Wakamiya, Minoru ^m   Saitou, Haruhisa ⁿ   Kakumu, Shinichi ^o   Hirofuji, Hideo ^p   Kumada, Takashi ^q   Kobayashi, Kenichi ^r   Kashima, Kei ^s   Inoue, Kyouichi ^t   Yamada, Goutarou ^u   Yamamoto, Shinichirou ^u   Onchi, Morikazu ^v   Miyaoka, Hiroaki ^w   Hayashi, Katsuhiro ^x   Kuroki, Kazuo ^y   Sata, Michio ^z   Yoshida, Hiroshi ^aa   more..

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e Hakodate Municipal Hospital   (Japan)

^f AKITA UNIVERSITY   (Japan)

^g AKITA CITY HOSPITAL   (Japan)

^h Kiyokawa Medical Center   (Japan)

ⁱ NIIGATA UNIVERSITY   (Japan)

^j Saiseikai Niigata Daini Hospital   (Japan)

^k Yamanashi Kosei Hospital   (Japan)

^l Shimobe Onsen Hospital   (Japan)

^m Minobusan Hospital   (Japan)

ⁿ Nirasaki Municipal Hospital   (Japan)

^o AICHI MEDICAL UNIVERSITY   (Japan)

^p Yokkaichi Municipal Hospital   (Japan)

^q OGAKI MUNICIPAL HOSPITAL   (Japan)

^r KANAZAWA UNIVERSITY   (Japan)

^s KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^t KANSAI MEDICAL UNIVERSITY   (Japan)

^u KAWASAKI MEDICAL SCHOOL   (Japan)

^v EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^w Saiseikai Matsuyama Hospital   (Japan)

^x UNIVERSITY OF MIYAZAKI   (Japan)

^y Health Insurance Chubu Hospital   (Japan)

^z KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aa Yame General Hospital   (Japan)

more..

Author keywords

Chronic hepatitis; Genotypes; Hepatitis C virus; Natural interferon

Indexed keywords

ALPHA INTERFERON; LYMPHOBLAST INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VIRUS LOAD; VIRUS TITRATION;

EID: 0036901855     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(02)00142-0     Document Type: Article

References (8)

1. Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986;315:1575-8.
2. Kasahara A, Hayashi N, Hiramatsu N, et al. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 1995;21:291-7.
3. Poynard T, Bedossa P, Chevallier M, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-62.
4. Reichard O, Foberg U, Fryden A, et al. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology 1994;19:280-5.
5. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996;6:112-9.
6. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
7. Pol S, Nalpas B, Bourliere M, et al. Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C. Hepatology 2000;31:1338-44.
8. Cummings KJ, Lee SM, West ES, et al. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: a meta-analysis of randomized trials. J Am Med Assoc 2001;285:193-9.